Lomexin 20 mg/g 30 ml cutaneous spray solution

Lomexin 20 mg/g 30 ml cutaneous spray solution it's a antifungal for topical use formulated for the effective treatment of skin mycosis and of fungal skin infections. Thanks to its active ingredient, the fenticonazole nitrate at 2%, Lomexin spray acts rapidly against a wide range of pathogens responsible for dermatomycosis (how Trichophyton, Microsporum, Epidermophyton), cutaneous candidiasis e pityriasis versicolor. His skin solution in 30 ml bottle with nebulizer guarantees a easy application also on areas that are difficult to reach and on areas covered with hair, such as scalp.

Lomexin spray is particularly suitable for treatment of fungal skin infections which ones tinea capitis, tinea corporis, tinea pedis (athlete's foot), tinea cruris, tinea manuum, tinea faciei, tinea barbae e tinea unguium. It is also effective against candidiasis of the skin (intertrigo, diaper candidiasis, perleche, facial, perineal and scrotal candidiasis), balanitis, balanoposthitis, onychia e paronychia. The spray formulation allows for a uniform distribution of the product, without greasing or staining the skin or clothes, and is easily removable with water.

The presence of propylene glycol among the excipients it helps to improve the skin penetration of the active ingredient, while the alcoholic solution promotes rapid drying. Lomexin 20 mg/g cutaneous spray solution is the ideal choice for those looking for a practical, rapid and targeted treatment of skin mycosis, ensuring effective action against the main dermatophyte fungi and yeasts responsible for skin infections.

INDICATIONS

Why is Lomexin 20 mg/g 30 ml cutaneous spray solution used? What is it for?

Lomexin 2% cream, Lomexin 2% skin spray, solution, Lomexin 2% skin solution, Lomexin 1% and 2% skin powder: • Dermatomycosis due to dermatophytes (Trichophyton, Microsporum, Epidermophyton) in different localizations: tinea capitis, tinea corporis, tinea cruris, tinea pedis (athlete's foot), tinea manuum, tinea faciei, tinea barbae, tinea unguium., Candidiasis of the skin (intertrigo, perleche, facial candidiasis, "diaper" candidiasis, perineal and scrotal); balanitis, balanoposthitis; onychia and paronychia., Pityriasis versicolor (from Pityrosporum orbiculare and P. ovale)., Otomycosis (from Candida or molds); only if there are no eardrum lesions present., Erythrasma., Mycosis with bacterial superinfections (from Gram positive bacteria).

ACTIVE INGREDIENTS AND EXCIPIENTS

What is the composition of Lomexin 20 mg/g 30 ml cutaneous spray solution?

Composition

Lomexin 2% cream 100 g of cream contains 2 g of fenticonazole nitrate. Excipients with known effects: 100 g of cream contain 5 g of propylene glycol, 3 g of cetyl alcohol, 1 g of hydrogenated lanolin. Lomexin 2% skin spray, solution 100 ml of solution contains 2 g of fenticonazole nitrate. Excipient with known effects: 100 ml of solution contains 35 g of propylene glycol. Lomexin 2% cutaneous solution 100 ml of solution contains 2 g of fenticonazole nitrate. Excipient with known effects: 100 ml of solution contains 77.50 g of propylene glycol. Lomexin 1% skin powder 100 g of powder contains 1 g of fenticonazole nitrate. Lomexin 2% skin powder 100 g of powder contains 2 g of fenticonazole nitrate.

Excipients

Lomexin 2% cream Propylene glycol Hydrogenated lanolin Refined almond oil Polyglycolic ester of fatty acids Cetyl alcohol Glyceryl monostearate Sodium edetate Purified water. Lomexin 2% skin spray, solution Alcohol Propylene glycol Purified water. Lomexin 2% cutaneous solution Alcohol Hydroxypropyl cellulose Purified water Propylene glycol. Lomexin 1% skin powder Hydrated colloidal silica Zinc oxide Talc. Lomexin 2% skin powder Hydrated colloidal silica Zinc oxide Talc.

DOSAGE

How is Lomexin 20 mg/g 30 ml cutaneous spray solution taken?

Lomexin should be applied 1-2 times a day, according to the doctor's opinion, after having washed and dried the injured part, using the formulation suitable for the location of the lesion. Lomexin 2% cream, it is indicated for the treatment of hairless skin, skin folds and mucous membranes; it is applied by rubbing lightly. It is used preferentially for dry mycoses: pityriasis versicolor, erythrasma, onychomycosis (in onychomycosis the cream should be applied with an occlusive bandage); the cream is suitable for use in male genital mycosis. Lomexin 2% skin spray, solution and 2% skin solution, they are indicated for localizations on the scalp and for skin areas covered by hair. Furthermore, the solution skin spray is easy and convenient to use for extensive mycosis and for difficult to reach areas. Lomexin 1% and 2% skin powder, It is used for athlete's foot and in general for intertriginous areas and moist lesions, both as a single treatment and as a complement to the cream. In foot infections it is recommended to also sprinkle the inside of socks and shoes with Lomexin powder. Lomexin 1% cutaneous powder is indicated for the prophylaxis of reinfections. In athlete's foot and onychomycosis, in order to avoid reinfections, it is advisable to continue the above treatment for one or two weeks after the disappearance of the symptoms. Lomexin is not greasy, does not stain and is easily removable with water.

CONTRAINDICATIONS AND SIDE EFFECTS

When should Lomexin 20 mg/g 30 ml cutaneous spray solution not be used and what side effects can it cause?

Contraindications

Hypersensitivity to the active substance or to any of the excipients (see the section "What is the composition of Lomexin 20 mg/g 30 ml cutaneous spray solution?"). Pregnancy ((see the section "Can Lomexin 20 mg/g 30 ml cutaneous spray solution be used during pregnancy and breastfeeding?")).

Side effects

When used as recommended, Lomexin is only poorly absorbed and no systemic side effects are expected. Prolonged use of products for topical use may cause sensitization phenomena ((see the section "What are the warnings of Lomexin 20 mg/g 30 ml cutaneous spray solution?")). The table below shows the undesirable effects, listed by system organ class according to MedDRA and by frequency: very common (≥1/10); common (≥1/100, less than 1/10); uncommon (≥1/1,000, less than 1/100); rare (≥1/10,000, less than 1/1,000); very rare (less than 1/10,000); not known (frequency cannot be estimated from the available data). Classification by systems and organs Frequency Preferred term Skin and subcutaneous tissue disorders Very rare Erythema, Pruritus, Rash, Rash erythematous, Skin irritation, Skin burning sensation Reporting of suspected adverse reactions Reporting of suspected adverse reactions that occur after authorization of the medicinal product is important, as it allows continuous monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at www.agenziafarmaco.gov.it/it/responsabili.

INTERACTIONS

Which medicines or foods can modify the effect of Lomexin 20 mg/g 30 ml cutaneous spray solution?

None known.

PREGNANCY AND BREASTFEEDING

Can Lomexin 20 mg/g 30 ml cutaneous spray solution be used during pregnancy and breastfeeding?

Although the percutaneous absorption of fenticonazole is rather poor, it is advisable not to use the medicine during pregnancy.

WARNINGS

What are the warnings of Lomexin 20 mg/g 30 ml cutaneous spray solution?

Warnings and precautions

Upon application to the lesion, a modest burning sensation may be felt which quickly disappears. The use, especially if prolonged, of products for topical use can give rise to sensitization phenomena. In this case, stop treatment and consult your doctor to institute suitable therapy. Important information about some excipients: Lomexin 2% cream, Lomexin 2% skin spray, solution, Lomexin 2% skin solution contain propylene glycol. They can cause skin irritation. Lomexin 2% cream contains cetyl alcohol. May cause local skin reactions (e.g. contact dermatitis). Lomexin 2% cream contains hydrogenated lanolin. May cause local skin reactions (e.g. contact dermatitis).

Overdose

No cases of overdose have been reported.

Driving vehicles and using machinery

Lomexin does not affect the ability to drive or use machines.

CONSERVATION

How is Lomexin 20 mg/g 30 ml cutaneous spray solution stored?

None.

FORMAT

What is the format of Lomexin 20 mg/g 30 ml cutaneous spray solution?

DRUG LEGAL TEXT

Content responsibility

This sheet contains information that is not intended to replace a doctor's diagnosis or advice, as only the doctor can draw up any prescription and give therapeutic indications. All contents must be understood and are of an exclusively informative nature and aimed exclusively at bringing to the attention of customers or potential customers in the pre-purchase phase of the products sold through this site. In case of pathologies, disorders or allergies it is always best to consult your doctor first.

Please note

The product names, ingredients and percentages indicated in the descriptions are purely indicative and may be subject to changes or updates by the manufacturing companies. Due to the impossibility of adapting to these updates in real time, the photos and technical information of the products included on Dottortili.com may differ from those shown on the label or otherwise disseminated by the manufacturing companies. The only identification element appears to be the ministerial code MINSAN. The online pharmacy Dottortili.com does not guarantee the truthfulness and timeliness of the information published and declines any responsibility for any errors, omissions or failure to update the same. Dottortili.com assumes no responsibility for damages of any nature that may arise from access to the information published.

Data source: Farmadati Italia

Website: www.farmadati.it

The Farmadati Italia database is used by almost all pharmacies, parapharmacies, herbalist shops, health shops, large-scale retail trade, computerized doctors, etc. thanks to the guarantee of historical reliability, seriousness and professionalism of the company on the national territory.

The Farmadati Italia S.r.l management system complies with the requirements of the UNI EN ISO 9001:2015 standards for quality management systems and UNI CEI ISO/IEC 27001:2017 for information security management systems.